Dipicolinic Acid

Dipicolinic Acid

SCHEMBL3972222

O=C([O-])c1cccc(C(=O)[O-])n1.[Na+].[Na+]

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Dipicolinic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CA2 known ✓ P00918 1/20 0.44
CA4 known ✓ P22748 1/20 0.44
PTGS1 known ✓ P23219 5/20 0.39
PTGS2 known ✓ P35354 4/20 0.39
KDM4E B2RXH2 2/20 0.56
ALOX15 P16050 1/20 0.56
TSHR P16473 1/20 0.56
ACMSD Q8TDX5 1/20 0.56
TDP1 Q9NUW8 1/20 0.56
CYP1A2 P05177 3/20 0.43
POLB P06746 1/20 0.43
PTGER1 P34995 8/20 0.41
CYP2C9 P11712 2/20 0.40
ALDH1A1 P00352 2/20 0.39
HPGD P15428 1/20 0.39
TBXA2R P21731 1/20 0.38
CYP2C19 P33261 1/20 0.38
PTGER3 P43115 1/20 0.38
PTGER2 P43116 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dipicolinic Acid SCHEMBL21802986 0.97 KDM4E (0.54) KDM4EALOX15TSHRACMSDTDP1
Dipicolinic Acid SCHEMBL3059430 0.95 KDM4E (0.56) KDM4EALOX15TSHRACMSDTDP1
Dipicolinic Acid SCHEMBL3340788 0.95 KDM4E (0.56) KDM4EALOX15TSHRACMSDTDP1
Dipicolinic Acid SCHEMBL3974346 0.95 KDM4E (0.56) KDM4EALOX15TSHRACMSDTDP1
Dipicolinic Acid SCHEMBL9753719 0.95 KDM4E (0.56) KDM4EALOX15TSHRACMSDTDP1
Dipicolinic Acid SCHEMBL2276246 0.95 KDM4E (0.56) KDM4EALOX15TSHRACMSDTDP1
Dipicolinic Acid SCHEMBL674980 0.95 KDM4E (0.56) KDM4EALOX15TSHRACMSDTDP1
Dipicolinic Acid SCHEMBL9491857 0.95 KDM4E (0.56) KDM4EALOX15TSHRACMSDTDP1
Dipicolinic Acid SCHEMBL7699646 0.95 KDM4E (0.56) KDM4EALOX15TSHRACMSDTDP1
Dipicolinic Acid SCHEMBL3974348 0.95 KDM4E (0.56) KDM4EALOX15TSHRACMSDTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111479913-B Compositions containing lanthanide metal complexes 罗地亚经营管理公司 2021-12-21 CN claimed
US-20210179975-A1 COMPOSITION CONTAINING LANTHANIDE METAL COMPLEX SPECIALTY OPERATIONS FRANCE (FR) 2021-06-17 US claimed
CN-111479913-A Compositions containing lanthanide metal complexes 罗地亚经营管理公司 2020-07-31 CN claimed
CN-114941170-B Method for improving 193nm laser irradiation hardness of calcium fluoride crystal 中国科学院上海硅酸盐研究所 2024-02-06 CN disclosed
CN-116539389-A Water-soluble trace element tracer and preparation method and application thereof 大庆信辰油田技术服务有限公司 2023-08-04 CN disclosed
US-11441105-B2 Composition containing lanthanide metal complex RHODIA OPERATIONS 2022-09-13 US disclosed
CN-114941170-A Method for improving 193nm laser irradiation hardness of calcium fluoride crystal 中国科学院上海硅酸盐研究所 2022-08-26 CN disclosed
CN-111479913-B Compositions containing lanthanide metal complexes 罗地亚经营管理公司 2021-12-21 CN disclosed
US-20210179975-A1 COMPOSITION CONTAINING LANTHANIDE METAL COMPLEX SPECIALTY OPERATIONS FRANCE (FR) 2021-06-17 US disclosed
CN-111479913-A Compositions containing lanthanide metal complexes 罗地亚经营管理公司 2020-07-31 CN disclosed
US-20090221816-A1 Process for the Asymmetric Epoxidation of Olefins LANXESS DEUTSCHLAND GMBH (DE) 2009-09-03 US disclosed
US-7544819-B2 Process for the asymmetric epoxidation of olefins LANXESS DEUTSCHLAND GMBH (DE) 2009-06-09 US disclosed
US-20050203303-A1 Process for the asymmetric epoxidation of olefins LANXESS DEUTSCHLAND GMBH (DE) 2005-09-15 US disclosed
EP-1247802-B1 Process for the production of peracetic acid KEMIRA OYJ (FI) 2004-12-22 EP disclosed
US-6677477-B2 FEEDING HYDROGEN PEROXIDE AND ACETIC ACID CONTINUOUSLY INTO AQUEOUS REACTION MEDIUM THAT CONTAINS HYDROGEN PEROXIDE, ACETIC ACID, PERACETIC ACID AND AN ACID CATALYST TO FORM PERACETIC ACID KEMIRA CHEMICALS OY (FI) 2004-01-13 US disclosed
US-20020193626-A1 Feeding hydrogen peroxide and acetic acid continuously into aqueous reaction medium that contains hydrogen peroxide, acetic acid, peracetic acid and an acid catalyst to form peracetic acid KEMIRA OYJ (FI) 2002-12-19 US disclosed
EP-1247802-A1 Process for the production of peracetic acid KEMIRA CHEMICALS OY (FI) 2002-10-09 EP disclosed
EP-0550634-A1 POLYHYDROXY FATTY ACID AMIDES IN BRIGHTENER-CONTAINING LIQUID DETERGENT COMPOSITIONS. PROCTER & GAMBLE (US) 1993-07-14 EP disclosed
WO-1992006172-A1 POLYHYDROXY FATTY ACID AMIDES IN BRIGHTENER-CONTAINING LIQUID DETERGENT COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1992-04-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050203303-A1 Process for the asymmetric epoxidation of olefins DUOX1, DUOX2, PPOX CA2 4415/4885CA4 3237/4885PTGS1 846/4885
US-20090221816-A1 Process for the Asymmetric Epoxidation of Olefins DUOX1, DUOX2, PPOX CA2 4415/4885CA4 3237/4885PTGS1 846/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.